- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04346927
Telerehabilitation for Patients Diagnosed With Coronavirus (COVID-19)
Investigation of the Effects of Exercise Using Telerehabilitation in Patients Diagnosed With Coronavirus (COVID-19) and Followed at Home
In December 2019, new coronavirus pneumonia (COVID-19) erupted in Wuhan (Hubei, China) and quickly spread from a single city to the entire country. It did not take long for this epidemic to spread to the world. After that, World Health Organization declared this epidemic disease as a pandemic. As of now, the number of coronavirus deaths increased to 108,281 worldwide. Total number of cases approached 1,800,000 according to the latest information. While the number of healed patients was highest in China, 77,525 people with COVID-19 recovered.
COVID-19 is a highly contagious respiratory infectious disease that can cause respiratory, physical and psychological dysfunction in patients. Respiratory rehabilitation reduces the patient's symptoms of dyspnea, relieves anxiety and depression, reduces the patient's need to apply to the hospital, increases functional capacity and improves the patient's quality of life. Respiratory rehabilitation, according to the feedback from China, is very important for patients in the clinical treatment and recovery process after treatment. Rehabilitation of people with mild disease after discharge is mainly based on improving physical fitness and psychological adaptation. It is also aimed to gradually restore the individual's ability to the activity before the disease and return to the community as soon as possible. Individuals with COVID-19 who have respiratory and / or limb dysfunction and chronic disease after discharge should receive respiratory rehabilitation therapy. According to the current findings of the patients discharged from severe acute respiratory syndrome (SARS-CoV) and Middle East respiratory syndrome (MERS) and the clinical experience of patients with Acute Respiratory Distress Syndrome (ARDS) patients who recovered after discharge, COVID-19 patients may have physical fitness, dyspnea after activity, and muscle atrophy. (Including respiratory muscles and trunk muscles) It is recommended to use respiratory videos and booklets as the main method for respiratory rehabilitation in isolated patients at home. Telerehabilitation method is also a different recommendation option for rehabilitation.
The purpose of this study is to investigate the effects of exercises performed by telerehabilitation in patients diagnosed with COVID-19 followed at home. It is aimed to use an innovative model based on the digitally supported, home-based exercise program.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
İstanbul, Turquie
- Istinye University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Having been diagnosed with COVID-19,
- Having been diagnosed in the last 1 week,
- Being between the ages of 18-70,
- Patients who continue to be followed at home
Exclusion Criteria:
- Hospitalization patients
- Having a serious cognitive impairment
- Having serious hearing and vision problems
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Study Group
The group to which the exercise protocol consisting of breathing exercises, posture exercises, peripheral muscle training and light aerobic exercises will be applied.
|
15 volunteers diagnosed with coronavirus will be included in experimental group.
An online exercise program has been created for individuals who will participate in the study.
This program is planned to continue 3-4 days a week, in a 30-minute session and for 6 weeks.
Treatment sessions will include breathing exercises, posture exercises, peripheral muscle exercises and light aerobic exercises.
Individuals were asked to participate in the research via telerehabilitation connection system and were told that they would do their exercises with a physiotherapist.
|
|
Comparateur actif: Control Group
group to be given an exercise brochure
|
15 volunteers diagnosed with coronavirus will be included in control group.The same exercises will be given to the control group as a brochure and they will be asked to do it for 6 weeks.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Visual Analogue Scale
Délai: 2 weeks
|
Visual Analogue Scale (VAS) is a horizontal line, 100 mm in length, and anchored by word descriptors at each end.
The VAS dyspnea score uses "no shortness of breath at all" and "maximum shortness of breath" .
The patient marks on the line the point that they feel represents the perception of their current state.
The distance (mm) between the beginning of the horizontal line and this mark represents the degree of dyspnea perception
|
2 weeks
|
|
Modified Borg Scale
Délai: 2 weeks
|
This scale used was a modified Borg scale of perceived exertion adapted to be appropriate for measuring fatigue.
This consisted of a vertical scale labelled 0-10, with corresponding verbal expressions of progressively increasing perceived sensation intensity.
(0 = no fatigue , 10 = maximal fatigue)
|
2 weeks
|
|
Leicester Cough Questionnaire
Délai: 2 weeks
|
Leicester Cough Questionnaire (LCQ) is an English-born self-reporting quality of life measure of chronic cough.
It consists of 19 items with a 7 point likert response scale (range from 1 to 7).
Each item is developed to assess symptoms during cough and impact of cough on three main domains: physical, psychological and social.
Scores are calculated as a mean of each domain and the total score is calculated by adding every domain score.
It generally takes about 5 minutes to be completed and it is designed for adults
|
2 weeks
|
|
Timed Up and Go
Délai: 2 weeks
|
The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down. During the test, the person is expected to wear their regular footwear and use any mobility aids that they would normally require |
2 weeks
|
|
30 Second Chair Stand Test
Délai: 2 weeks
|
The 30-s Chair Stand Test consists of standing up and sitting down from a chair as many times as possible within 30 seconds.
A standard chair without backrest, but with armrests is used.
Initially, the person is seated on the chair with his backs upright.
They are told to look forward with their arms folded in their chest and rise at their preferred speed after the command "1, 2, 3, go".
All trials must be carried out using the same chair and similar environmental conditions.
|
2 weeks
|
|
The Beck Depression Inventory
Délai: 2 weeks
|
The Beck Depression Inventory (BDI) is a 21-item, self-rated scale that evaluates key symptoms of depression.
Individual scale items are scored on a 4-point continuum (0=least, 3=most), with a total summed score range of 0-63.
Higher scores indicate greater depressive severity.
Two subscales include a cognitive-affective subscale and a somatic-performance subscale
|
2 weeks
|
|
The Beck Anxiety Inventory
Délai: 2 weeks
|
The Beck Anxiety Inventory (BAI) is a 21-question multiple-choice self-report inventory that is used for measuring the severity of anxiety in children and adults.The questions used in this measure ask about common symptoms of anxiety .
It is designed for individuals who are of 17 years of age or older and takes 5 to 10 minutes to complete.
Several studies have found the Beck Anxiety Inventory to be an accurate measure of anxiety symptoms in children and adults
|
2 weeks
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 009 (Nahrain Medical Research Collective (NMRC))
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .